Interferons (IFN) are a group of polypeptides that have in common the ability to induce in cells resistance to a broad spectrum of viral infections. Immune or y-IFN differs in several distinct ways from a-IFN (leukocyte derived) and fl-IFN (fibroblast derived) on the basis of both biologic and physicochemical criteria (1-3). Leukocyte and fibroblast IFN are released when cells become infected by virus; immune IFN, on the other hand, is produced by lymphoid cells during the course of an immune response. There are a number of correlations between the stimulation of T cells and the release of immune IFN. For example, culturing lymphoid cells with T cell mitogens or with antigens that stimulate a strong T cell response leads to the production of immune IFN (4-9). Recently, there have been reports that a human T cell line (1(3) and a number of murine T cell clones (11) release immune IFN upon culture with PHA or Con A. Although these cell lines were probably of the T cell lineage, they lacked any functionally defined T cell characteristics. Kirchner et al. (8) reported the provocative finding that in murine mixed lymphocyte culture (MLC), differences in class I (H-2K or D) antigens induced more IFN production than differences in the I region or the Mls locus. This was true even though I region or Mls differences were better stimulators of T cell proliferation. This finding suggested to us that immune IFN may be released by cytotoxic T lymphocytes (CTL) that are H-2K, D region specific. Additionally, treatment of antigen-stimulated spleen cells with anti-Lyt-2,3 antisera plus complement ((2') has been shown to greatly reduce the level of IFN, although in these experiments anti-immunoglobulin, anti-Ia, and anti-Lyt-1 sera also had the same effect (12). Moreover, a correlation has been demonstrated between IFN release and the development of CTL activity in MLC in which the responders came from primed or normal mice (9). Farrar and colleagues (13) have pointed to the correlation between immune IFN release and CTL activation, and we have also found a strong correlation between CTL activity and IFN production (unpublished observations).
that CTL can deliver a "one-two punch" at a local site: death to a target cell and the local release of immune IFN.
Materials and Methods
Mice. BALB/cAnN (H-2d), BALB.B (H-2b), and (B10.BR × B10.D2)F1 (H-2 k × H-2 d) mice were bred at the Center for Cancer Research, Massachusetts Institute of Technology. B 10.D2/ nSnJ and B10.BR/SgSnJ mice were purchased from The Jackson Laboratory, Bar Harbor, ME. All animals were used at 8-20 wk of age.
Antisera Treatment. Thy-1 positive cells were removed from normal spleen cells by treatment with two monoclonal anti-Thy-1 antibodies followed by rabbit C'. Normal spleen cells were suspended at 10 7 cells/ml in Hanks' balanced salt solution containing ascites fluid from mice bearing hybridoma clone 13.4 (14) plus T24 culture supernatant (15) at final dilutions of 1:100 and 1:50, respectively. After 30 min at 4°C, cells were resuspended at 5 × 106/ml in a 1:20 dilution of a selected rabbit C' and incubated for 45 min at 37°C.
Cloned CTL. The history and specificity of the crl5 cloned CTL line has been described (16) . The cells derive from a (BI0.BR × B10.D2)F1 mouse and are specific for a BALB background minor histocompatibility antigen plus H-2D a. The cells were cloned by limiting dilution (at 0.3 cells/well) and maintained as described by Glasebrook and Fitch (17) by weekly subculture in medium containing IL-2 plus irradiated BALB/c spleen cells. The medium used was RPMI 1640 (Microbiological Associates, Walkersville, MD) containing 5% fetal calf serum, 5 × 10 -5 M 2-mercaptoethanol (MLC medium), supplemented with 50 mM a-methyl mannoside, and 20% medium from spleen cells (5 × 10S/ml) cultured for 24 h with 2 /tg/ml concanavalin A (Con A).
The spleen Con A supernatant can be replaced by the supernatant from AOFS 21.10.9 T hybridoma ceils cultured with 10 #g/ml Con A for 24 h (18) IFNProduction. cr15 cells were harvested 7-12 d after the previous subculture and washed twice in RPMI 1640 medium containing 5% FCS. 2 × 105 to 5 × 10 s cells/ml were cultured in 2 ml volumes in Costar wells (Costar, Data Packaging, Cambridge, MA) in MLC medium supplemented with 20% AOFS Sup with 2 × 106/ml irradiated (1,300 rad), T cell-depleted spleen cells, or Con A. Usually, after 2 d incubation at 37°C, the cultures were harvested, and centrifuged at 500 g for 10 min. The supernatants were passed through a 0.2/tm filter and stored frozen. 0.2 ml cultures in Costar 3596 wells were pulsed on day 2-3 for 4 h with 2/~Ci [ZH]thymidine for 4 h to assess the rate of DNA synthesis.
IFNAssay. IFN activity was determined in a conventional cytopathic effect (CPE) inhibition assay of vesicular stomatitis virus (VSV) on L cells (1) . L cells were seeded into 96-well microtiter plates (Costar 3596) in a volume of 100 #l/well. To this was added 50 pl of serially diluted test supernatants. 24 h later, 50/~1 of 200 TCIDs0 VSV was added to each well. 48 h post-infection, the tissue monolayer was scored visually for virus-induced CPE. The IFN titer is defined as the reciprocal of the highest dilution showing at least 50% inhibition of CPE in triplicate cultures.
IFN Neutralization. Supernatant from antigen or mitogen-induced crl5 cells was dialyzed
for 24 h against 0.1 M glycine-HCl, 0.15 M NaCI, pH 2.0 buffer, followed by dialysis for 48 h against phosphate-buffered saline, pH 7.2, and RPMI 1640 medium. Rabbit anti-mouse immune IFN ~erum was generously provided by Dr. Howard M. Johnson, University of Texas, Galveston, TX, and was used according to his protocol (19) . Briefly, diluted antiserum (1:30) was mixed with an equal volume of serially diluted IFN supernatant and incubated at room temperature for 1 h. 50/~1 of each sample was then added to L cell monolayers and tested for VSV inhibition as described above. and growth factors remain dependent on both antigenic stimulation and IL-2 for optimum growth. The cytotoxic specificity of crl5 (B10.BR × B10.D2)F1 CTL for a BALB background minor histocompatibility antigen recognized in the context of H-2 d is illustrated by the data in Table I : the CTL lyse BALB/c(H-2 d) targets, but not BALB.B(H-2 ~) targets, because of H-2 restriction, or B10.D2(H-2 d) targets, which lack the foreign minor antigen; they do lyse the (BALB.B × B10.D2)F1 target, which carries the BALB minor histocompatibility antigen plus H-2 d (16) . The crl5 CTL used in the following experiments were typed with a battery of antisera and shown to be 100% sensitive to lysis with anti-H-2 d, anti-H-2 k, anti-Thy-l.2, and anti-Lyt-2.2 antibodies and C' (data not shown).
Results

Characteristics of Cloned CTL. Clones of CTL isolated and maintained with antigen
IFN Production by crl5 in Response to
Antigens. When cultured in the presence of T cell-depleted, irradiated allogeneic stimulator cells in IL-2 supplemented medium free of IFN (i.e., AOFS Sup), crl5 cells were found to make significant levels of IFN in 2-d cultures (Table II) . IFN produced by these cultures was of the immune type based on its sensitivity to pH 2.0 and on its inactivation by anti-mouse immune IFN serum (>98% loss of IFN activity in each case), crl5 cultured alone, i.e., in the absence of antigen but in IL-2 supplemented medium, as above, failed to produce IFN. Additionally, erlS, when cultured with semisyngeneic cells or H-2 mismatched BALB.B cells, produced substantially less immune IFN (1:96) than that made in response to alloantigenic stimulation (1:768 and 1:3,072). The possibility that immune IFN was produced by the T cell-depleted, irradiated stimulator cells in our culture system was 1201 effectively ruled out because Con A stimulation of these cells alone failed to induce IFN production; Con A is known to promote IFN production in normal whole spleen cell cultures (see Table III ). Thus, the cloned CTL line described here makes immune IFN in an antigen-dependent fashion with the same specificity that regulates its CTL activity.
As previously described, crl5 require both antigen-specific stimulation and IL-2 for growth. In both sets of experiments (Table II) , thymidine incorporation as well as IFN production was maximal in crl5 cultures stimulated with antigen-bearing cells.
Effect of Con A Stimulation on IFN Production by cr l 5. crl5 were tested for their ability to make immune IFN in the absence of antigen when stimulated with the T cell mitogen, Con A. Cells cultured with Con A produced high levels of IFN in a dosedependent fashion; in the same experiments there was a fourfold greater IFN titer (12,288 vs. 3,072) in Con A-stimulated cr15 cells as compared with antigen-stimulated cells. The ability of crl5 cells to make IFN upon addition of Con A further confirms the source of IFN to be the CTL themselves, because no additional cells were added. Of interest in this experiment was the sharp reduction in proliferative activity by Con A-stimulated crl5 cells, despite large amounts of secreted IFN.
The IFN activity induced by Con A was also shown to be >94% susceptible to overnight dialysis at pH 2.0 (data not shown) and treatment with anti-immune IFN serum. The IFN titer of a typical 24-h Con A induced spleen cell supernatant is also shown in Table III . Finally, we have shown that an alloreactive, cloned CTL line, G4, derived from a BALB.B mouse, specific for H-2 d antigens, also releases IFN in response to Con A or antigen stimulation.
Discussion
The results presented here demonstrating antigen-or mitogen-induced release of immune IFN by cloned CTL lines explain the correlations that have been noted between CTL stimulation and IFN production (7-9, 13, 20) . In what way immune IFN participates in CTL function remains to be determined. However, there are several possible ways in which IFN could be of importance. IFN could contribute to the killing of target cells recognized by the CTL, i.e., it could provide the "lethal-hit" to the target. Immune IFN may also be an interleukin which, when released by CTL, acts in some immunoregulatory capacity on other immune cells responding to the same antigen; there is a substantial body of information supporting this role for immune IFN (1, 3) . However, the most straightforward interpretation of the finding that CTL release IFN on binding antigen is that IFN contains the spread of antigen. For example, CTL that recognize and kill virus-infected cells would help prevent the spread of infection if, in addition, they released IFN at the local site of infection. IFN may also inhibit tumor growth or enhance the activity of other killer mechanisms at the site ofa CTL-target recognition event (21, 22) . Finally, it should be kept in mind that our results demonstrating IFN production by CTL do not rule out the possibility that immune IFN is made by other lymphoid cells as well.
Summary
Interferon (IFN) was found to be secreted by cloned lines of murine cytotoxic T lymphocytes in response to mitogenic or antigen specific stimulation. The IFN produced was shown to be of the immune type based on its sensitivity to pH 2.0 and on the ability of an antiserum to immune IFN to neutralize the antiviral activity.
